nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—IL2—vaginal cancer	0.953	1	CbGaD
Pseudoephedrine—IL2—epithelium—vaginal cancer	0.00392	0.113	CbGeAlD
Pseudoephedrine—IL2—uterine cervix—vaginal cancer	0.00389	0.112	CbGeAlD
Pseudoephedrine—IL2—uterus—vaginal cancer	0.00324	0.0934	CbGeAlD
Pseudoephedrine—IL2—female reproductive system—vaginal cancer	0.00291	0.0839	CbGeAlD
Pseudoephedrine—NFATC1—female gonad—vaginal cancer	0.0029	0.0835	CbGeAlD
Pseudoephedrine—TNF—vagina—vaginal cancer	0.00275	0.0792	CbGeAlD
Pseudoephedrine—IL2—female gonad—vaginal cancer	0.00265	0.0764	CbGeAlD
Pseudoephedrine—NFATC1—Downstream signaling in naïve CD8+ T cells—IFNA1—vaginal cancer	0.0014	0.113	CbGpPWpGaD
Pseudoephedrine—IL2—Downstream signaling in naïve CD8+ T cells—IFNA1—vaginal cancer	0.00119	0.0955	CbGpPWpGaD
Pseudoephedrine—NFATC1—Calcium signaling in the CD4+ TCR pathway—IL2—vaginal cancer	0.00112	0.0902	CbGpPWpGaD
Pseudoephedrine—IL2—Cytokine Signaling in Immune system—EIF4A3—vaginal cancer	0.001	0.0804	CbGpPWpGaD
Pseudoephedrine—ADRA1A—epithelium—vaginal cancer	0.000777	0.0224	CbGeAlD
Pseudoephedrine—MAOA—uterine cervix—vaginal cancer	0.000763	0.022	CbGeAlD
Pseudoephedrine—ADRB1—female reproductive system—vaginal cancer	0.00073	0.021	CbGeAlD
Pseudoephedrine—NFATC1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—vaginal cancer	0.000725	0.0583	CbGpPWpGaD
Pseudoephedrine—SLC6A4—female reproductive system—vaginal cancer	0.000705	0.0203	CbGeAlD
Pseudoephedrine—MAOA—urethra—vaginal cancer	0.000701	0.0202	CbGeAlD
Pseudoephedrine—MAOA—endometrium—vaginal cancer	0.00069	0.0199	CbGeAlD
Pseudoephedrine—MAOA—mammalian vulva—vaginal cancer	0.000668	0.0192	CbGeAlD
Pseudoephedrine—MAOA—uterus—vaginal cancer	0.000636	0.0183	CbGeAlD
Pseudoephedrine—SLC6A2—female reproductive system—vaginal cancer	0.000621	0.0179	CbGeAlD
Pseudoephedrine—ADRA2A—uterine cervix—vaginal cancer	0.000585	0.0169	CbGeAlD
Pseudoephedrine—NFATC1—Downstream signaling in naïve CD8+ T cells—IL2—vaginal cancer	0.000581	0.0467	CbGpPWpGaD
Pseudoephedrine—MAOA—female reproductive system—vaginal cancer	0.000572	0.0165	CbGeAlD
Pseudoephedrine—NFATC1—AP-1 transcription factor network—IL2—vaginal cancer	0.000554	0.0446	CbGpPWpGaD
Pseudoephedrine—ADRA2A—urethra—vaginal cancer	0.000538	0.0155	CbGeAlD
Pseudoephedrine—ADRA2A—endometrium—vaginal cancer	0.00053	0.0153	CbGeAlD
Pseudoephedrine—MAOA—female gonad—vaginal cancer	0.00052	0.015	CbGeAlD
Pseudoephedrine—MAOA—vagina—vaginal cancer	0.000517	0.0149	CbGeAlD
Pseudoephedrine—ADRA2A—mammalian vulva—vaginal cancer	0.000512	0.0148	CbGeAlD
Pseudoephedrine—NFATC1—Glucocorticoid receptor regulatory network—IL2—vaginal cancer	0.000488	0.0393	CbGpPWpGaD
Pseudoephedrine—ADRA2A—uterus—vaginal cancer	0.000488	0.0141	CbGeAlD
Pseudoephedrine—TNF—Downstream signaling in naïve CD8+ T cells—IFNA1—vaginal cancer	0.000442	0.0355	CbGpPWpGaD
Pseudoephedrine—ADRA2A—female reproductive system—vaginal cancer	0.000439	0.0126	CbGeAlD
Pseudoephedrine—ADRA2A—female gonad—vaginal cancer	0.000399	0.0115	CbGeAlD
Pseudoephedrine—ADRA2A—vagina—vaginal cancer	0.000397	0.0114	CbGeAlD
Pseudoephedrine—NFATC1—Immune System—EIF4A3—vaginal cancer	0.000386	0.031	CbGpPWpGaD
Pseudoephedrine—TNF—IL27-mediated signaling events—IL2—vaginal cancer	0.000385	0.031	CbGpPWpGaD
Pseudoephedrine—IL2—Cytokine Signaling in Immune system—IFNA1—vaginal cancer	0.000374	0.0301	CbGpPWpGaD
Pseudoephedrine—TNF—Cytokines and Inflammatory Response—IL2—vaginal cancer	0.000374	0.03	CbGpPWpGaD
Pseudoephedrine—CYP2D6—female reproductive system—vaginal cancer	0.00034	0.0098	CbGeAlD
Pseudoephedrine—IL2—Immune System—EIF4A3—vaginal cancer	0.000327	0.0263	CbGpPWpGaD
Pseudoephedrine—TNF—Toll-like Receptor Signaling Pathway—IFNA1—vaginal cancer	0.000312	0.0251	CbGpPWpGaD
Pseudoephedrine—CYP2D6—female gonad—vaginal cancer	0.000309	0.00891	CbGeAlD
Pseudoephedrine—TNF—IL23-mediated signaling events—IL2—vaginal cancer	0.00029	0.0233	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—IFNA1—vaginal cancer	0.000248	0.0199	CbGpPWpGaD
Pseudoephedrine—TNF—Aryl Hydrocarbon Receptor Pathway—IL2—vaginal cancer	0.000244	0.0196	CbGpPWpGaD
Pseudoephedrine—TNF—Regulation of toll-like receptor signaling pathway—IFNA1—vaginal cancer	0.000244	0.0196	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—IFNA1—vaginal cancer	0.000233	0.0187	CbGpPWpGaD
Pseudoephedrine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—vaginal cancer	0.000228	0.0184	CbGpPWpGaD
Pseudoephedrine—TNF—Downstream signaling in naïve CD8+ T cells—IL2—vaginal cancer	0.000183	0.0147	CbGpPWpGaD
Pseudoephedrine—TNF—Folate Metabolism—IL2—vaginal cancer	0.000183	0.0147	CbGpPWpGaD
Pseudoephedrine—TNF—Allograft Rejection—IL2—vaginal cancer	0.000158	0.0127	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—IFNA1—vaginal cancer	0.000144	0.0116	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—IFNA1—vaginal cancer	0.000122	0.00982	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—IL2—vaginal cancer	0.000115	0.00923	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—IL2—vaginal cancer	5.97e-05	0.0048	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—IFNA1—vaginal cancer	5.49e-05	0.00442	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—IL2—vaginal cancer	4.41e-05	0.00354	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—IL2—vaginal cancer	3.86e-05	0.0031	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—IL2—vaginal cancer	2.27e-05	0.00183	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—IL2—vaginal cancer	1.91e-05	0.00154	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—IL2—vaginal cancer	1.87e-05	0.0015	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—IL2—vaginal cancer	1.73e-05	0.00139	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—IL2—vaginal cancer	1.7e-05	0.00136	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—IL2—vaginal cancer	1.55e-05	0.00124	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—IL2—vaginal cancer	1.44e-05	0.00115	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IL2—vaginal cancer	1.4e-05	0.00113	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL2—vaginal cancer	1.3e-05	0.00105	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL2—vaginal cancer	1.02e-05	0.000824	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL2—vaginal cancer	1e-05	0.000806	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL2—vaginal cancer	8.29e-06	0.000666	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL2—vaginal cancer	7.7e-06	0.000619	CbGpPWpGaD
